Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206269747> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W3206269747 endingPage "225" @default.
- W3206269747 startingPage "224" @default.
- W3206269747 abstract "Metastatic disease is the most common malignancy of the bone and the skeleton is one of the preferential sites for metastases of solid tumor. Osteotropic radiopharmaceuticals are bone seeking agents which target skeleton due to their osteoblastic activity. The most common in clinical use is Sodium-18 fluoride (Na18F).18F-NaF PET/CT plays essential role in initial staging, detection of suspected metastases, suspected progression of osseous metastases or treatment monitoring in many types of cancer, such as prostate, breast and lung cancer. Additionally, the role18F-NaF PET/CT in the diagnostics of thyroid cancer, renal cell cancer, multiple myeloma and metastatic primary bone tumors is discussed.Specific oncotropic PET agents are tumor targeting compounds, such as Iodine-124 for metastatic thyroid cancer, and somatostatin analogs (Ga-68DOTA-octreotide/octreotate) for neuroendocrine neoplasms. These tracers disclose bone metastases in the malignancies. Multiple tracers for prostate cancer are presented with varying ability to target malignant skeletal disease. Hormone receptor imaging is presented, FES PET is a prime example to demonstrate estrogen receptor positive skeletal disease.Non-specific oncotropic Agents are important in the detection of skeletal metastases. Actually, the most common PET tracer, F-18 fluorodeoxyglucose (18F-FDG), plays an important role in the diagnosis of many malignancies. However, the differential diagnosis and sensitivity may sometimes cause problems which should be identified. F-18 (C-11) Choline is associated with lipid synthesis and more sensitive than conventional bone scintigraphy in the diagnosis of bone metastases of prostate cancer. On the contrary, fluorothymidine (18F-FLT) which targets DNA and cellular proliferation, is not sensitive at all the in the follow-up of skeletal metastases.This article provides an overview about the diagnostics of bone metastases. Additionally, practical pitfalls are presented as well as new ideas how to improve diagnostics, such as quantitation methods and double-tracer techniques." @default.
- W3206269747 created "2021-10-25" @default.
- W3206269747 creator A5030920716 @default.
- W3206269747 creator A5037413888 @default.
- W3206269747 creator A5039858148 @default.
- W3206269747 creator A5042824986 @default.
- W3206269747 creator A5067420403 @default.
- W3206269747 creator A5082094779 @default.
- W3206269747 creator A5086202805 @default.
- W3206269747 date "2021-10-01" @default.
- W3206269747 modified "2023-10-16" @default.
- W3206269747 title "Understanding the gait pattern in patients undergoing proximal tibial endoprosthetic reconstructions for bone tumours" @default.
- W3206269747 cites W1996759460 @default.
- W3206269747 cites W2117613441 @default.
- W3206269747 cites W2158640105 @default.
- W3206269747 cites W2766950150 @default.
- W3206269747 cites W2783532351 @default.
- W3206269747 doi "https://doi.org/10.1016/j.gaitpost.2021.09.116" @default.
- W3206269747 hasPublicationYear "2021" @default.
- W3206269747 type Work @default.
- W3206269747 sameAs 3206269747 @default.
- W3206269747 citedByCount "0" @default.
- W3206269747 crossrefType "journal-article" @default.
- W3206269747 hasAuthorship W3206269747A5030920716 @default.
- W3206269747 hasAuthorship W3206269747A5037413888 @default.
- W3206269747 hasAuthorship W3206269747A5039858148 @default.
- W3206269747 hasAuthorship W3206269747A5042824986 @default.
- W3206269747 hasAuthorship W3206269747A5067420403 @default.
- W3206269747 hasAuthorship W3206269747A5082094779 @default.
- W3206269747 hasAuthorship W3206269747A5086202805 @default.
- W3206269747 hasConcept C121608353 @default.
- W3206269747 hasConcept C126322002 @default.
- W3206269747 hasConcept C126838900 @default.
- W3206269747 hasConcept C142724271 @default.
- W3206269747 hasConcept C2776049877 @default.
- W3206269747 hasConcept C2777783956 @default.
- W3206269747 hasConcept C2779013556 @default.
- W3206269747 hasConcept C2779399171 @default.
- W3206269747 hasConcept C2779761222 @default.
- W3206269747 hasConcept C2780192828 @default.
- W3206269747 hasConcept C530470458 @default.
- W3206269747 hasConcept C71924100 @default.
- W3206269747 hasConceptScore W3206269747C121608353 @default.
- W3206269747 hasConceptScore W3206269747C126322002 @default.
- W3206269747 hasConceptScore W3206269747C126838900 @default.
- W3206269747 hasConceptScore W3206269747C142724271 @default.
- W3206269747 hasConceptScore W3206269747C2776049877 @default.
- W3206269747 hasConceptScore W3206269747C2777783956 @default.
- W3206269747 hasConceptScore W3206269747C2779013556 @default.
- W3206269747 hasConceptScore W3206269747C2779399171 @default.
- W3206269747 hasConceptScore W3206269747C2779761222 @default.
- W3206269747 hasConceptScore W3206269747C2780192828 @default.
- W3206269747 hasConceptScore W3206269747C530470458 @default.
- W3206269747 hasConceptScore W3206269747C71924100 @default.
- W3206269747 hasLocation W32062697471 @default.
- W3206269747 hasOpenAccess W3206269747 @default.
- W3206269747 hasPrimaryLocation W32062697471 @default.
- W3206269747 hasRelatedWork W2366023954 @default.
- W3206269747 hasRelatedWork W2375435548 @default.
- W3206269747 hasRelatedWork W2393632993 @default.
- W3206269747 hasRelatedWork W2402854484 @default.
- W3206269747 hasRelatedWork W2610088533 @default.
- W3206269747 hasRelatedWork W2902148150 @default.
- W3206269747 hasRelatedWork W2945750792 @default.
- W3206269747 hasRelatedWork W4282937734 @default.
- W3206269747 hasRelatedWork W4298087892 @default.
- W3206269747 hasRelatedWork W4321371982 @default.
- W3206269747 hasVolume "90" @default.
- W3206269747 isParatext "false" @default.
- W3206269747 isRetracted "false" @default.
- W3206269747 magId "3206269747" @default.
- W3206269747 workType "article" @default.